
Feb 21 (Reuters) - FDA:
FDA: CLARIFIES POLICIES FOR COMPOUNDERS AS NATIONAL GLP-1 SUPPLY BEGINS TO STABILIZE
FDA: DOES NOT INTEND TO TAKE ACTION AGAINST COMPOUNDERS FOR FD&C ACT VIOLATIONS DEPENDING ON SEMAGLUTIDE INJECTION INCLUSION ON DRUG SHORTAGE LIST
FDA: WORKING TO DETERMINE WHETHER DEMAND OR PROJECTED DEMAND FOR DULAGLUTIDE, LIRAGLUTIDE DRUG IN SHORTAGE EXCEEDS AVAILABLE SUPPLY
Further company coverage: [NOVOb.CO]